Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lineage Cell Therapeutics (LCTX) Capital Leases (2016 - 2025)

Historic Capital Leases for Lineage Cell Therapeutics (LCTX) over the last 12 years, with Q3 2025 value amounting to $40000.0.

  • Lineage Cell Therapeutics' Capital Leases fell 5000.0% to $40000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $40000.0, marking a year-over-year decrease of 5000.0%. This contributed to the annual value of $67000.0 for FY2024, which is 2637.36% down from last year.
  • According to the latest figures from Q3 2025, Lineage Cell Therapeutics' Capital Leases is $40000.0, which was down 5000.0% from $48000.0 recorded in Q2 2025.
  • In the past 5 years, Lineage Cell Therapeutics' Capital Leases registered a high of $133000.0 during Q1 2023, and its lowest value of $12000.0 during Q3 2021.
  • Over the past 5 years, Lineage Cell Therapeutics' median Capital Leases value was $51000.0 (recorded in 2025), while the average stood at $57684.2.
  • In the last 5 years, Lineage Cell Therapeutics' Capital Leases plummeted by 7419.35% in 2021 and then skyrocketed by 50625.0% in 2023.
  • Quarter analysis of 5 years shows Lineage Cell Therapeutics' Capital Leases stood at $30000.0 in 2021, then skyrocketed by 180.0% to $84000.0 in 2022, then rose by 8.33% to $91000.0 in 2023, then fell by 26.37% to $67000.0 in 2024, then crashed by 40.3% to $40000.0 in 2025.
  • Its Capital Leases stands at $40000.0 for Q3 2025, versus $48000.0 for Q2 2025 and $51000.0 for Q1 2025.